Read more about Merck says it has first effective antiviral pill against Covid-19 pandemic on Business Standard. Drug cuts hospitalisation, deaths by 50%, shows an analysis of a late-stage trial
& Co’s Covid-19 antiviral pill molnupiravir reduced the risk of hospitalisation or death by 50 per cent in an interim analysis of a late-stage trial, findings that could give doctors another potent virus-fighting tool. The company is halting the study and will seek an emergency-use authorization from the as quickly as possible, Chief Executive Officer Rob Davis said in an interview. also plans to submit applications to regulators in other countries.
